<DOC>
	<DOCNO>NCT00568230</DOCNO>
	<brief_summary>Improvement heart failure moderate severe mitral regurgitation use percutaneously deliver implanted device .</brief_summary>
	<brief_title>Safety Efficacy Percutaneous Transvenous Mitral Annuloplasty Device Reduce Mitral Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>symptomatic heart failure moderate severe mitral regurgitation 20 50 % LVEF mitral regurgitation organic origins recent intervention severe comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>heart failure</keyword>
	<keyword>mitral regurgitation</keyword>
</DOC>